Tunable Protease-Activatable Virus Nanonodes
暂无分享,去创建一个
Eric J. Gomez | O. Igoshin | J. Silberg | Abhinav Tiwari | M. Agbandje-McKenna | J. Suh | C. Dempsey | Kim Van Vliet | M. Ho | J. Judd | Christopher Dempsey
[1] Wolfgang Jahnke and Daniel A. Erlanson. Fragment-based approaches in drug discovery , 2013 .
[2] Paul Steinbach,et al. Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. , 2013, Cancer research.
[3] J. Silberg,et al. Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity , 2012, Molecular therapy. Nucleic acids.
[4] P. Prevelige,et al. Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.
[5] Drew Endy,et al. Engineered cell-cell communication via DNA messaging , 2012, Journal of biological engineering.
[6] Jennifer A. Getz,et al. Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[7] Ramamoorthy Ramesh,et al. Virus-based piezoelectric energy generation. , 2012, Nature nanotechnology.
[8] D. Turk,et al. Protease signalling: the cutting edge , 2012, EMBO Journal.
[9] Massimo Coletta,et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. , 2012, Molecular aspects of medicine.
[10] Yun Jung Lee,et al. Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes , 2009, Science.
[11] M. S. Chapman,et al. Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex. , 2009, Virology.
[12] T. Baker,et al. Heparin binding induces conformational changes in Adeno-associated virus serotype 2. , 2009, Journal of structural biology.
[13] Nico A J M Sommerdijk,et al. A virus-based single-enzyme nanoreactor. , 2007, Nature nanotechnology.
[14] M. Francis,et al. Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins. , 2007, Journal of the American Chemical Society.
[15] George M. Whitesides,et al. Multivalency in Ligand Design , 2006 .
[16] R. Cattaneo,et al. Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. , 2006, Cancer research.
[17] Andries Zijlstra,et al. Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.
[18] S. Whelan,et al. Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.
[19] T. Weber,et al. Altering AAV tropism with mosaic viral capsids. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Zhang,et al. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo , 2003, Gene Therapy.
[22] Wendell A. Lim,et al. Rewiring MAP Kinase Pathways Using Alternative Scaffold Assembly Mechanisms , 2003, Science.
[23] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[24] L. Cantley,et al. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries , 2001, Nature Biotechnology.
[25] T. Conlon,et al. Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism , 2000, Journal of Virology.
[26] G. Deléage,et al. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 , 1999, Nature Medicine.
[27] F. Cosset,et al. A gene delivery system activatable by disease-associated matrix metalloproteinases. , 1997, Human gene therapy.
[28] A. Helenius,et al. The role of the adenovirus protease on virus entry into cells. , 1996, The EMBO journal.
[29] M. Krečmerová,et al. Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.
[30] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[31] I. Weissman,et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus , 1988, Cell.
[32] P. Choppin,et al. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.